Frontline ALK, EGFR Inhibition in Non-Small Cell Lung Cancer

0 Views
administrator
administrator
07/14/23

Panelists discuss the frontline administration of ALK and EGFR inhibitors for patients with advanced non-small cell lung caner.

For more from this discussion, visit http://www.onclive.com/peer-exchange/nsclc-needs

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next